According to CTI BioPharma
's latest financial reports the company has C$84.59 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | C$0.10 B | 30.05% |
2021-12-31 | C$83.4 M | 24.71% |
2020-12-31 | C$66.87 M | 52.1% |
2019-12-31 | C$43.96 M | -51.85% |
2018-12-31 | C$91.31 M | 68.06% |
2017-12-31 | C$54.33 M | -8.11% |
2016-12-31 | C$59.13 M | -66.74% |
2015-12-31 | C$0.17 B | 116.01% |
2014-12-31 | C$82.31 M | 7.94% |
2013-12-31 | C$76.25 M | 52.05% |
2012-12-31 | C$50.15 M | 4.79% |
2011-12-31 | C$47.86 M | 111.4% |
2010-12-31 | C$22.63 M | -43.09% |
2009-12-31 | C$39.78 M | 206.63% |
2008-12-31 | C$12.97 M | -29.11% |
2007-12-31 | C$18.3 M | -70.8% |
2006-12-31 | C$62.68 M | -21.84% |
2005-12-31 | C$80.19 M | -42.38% |
2004-12-31 | C$0.13 B | 17.15% |
2003-12-31 | C$0.11 B | -46.37% |
2002-12-31 | C$0.22 B | -45.67% |
2001-12-31 | C$0.40 B | 75.68% |
2000-12-31 | C$0.23 B | 573.27% |
1999-12-31 | C$34.47 M | 409.55% |
1998-12-31 | C$6.76 M | -46.8% |
1997-12-31 | C$12.71 M | 68.8% |
1996-12-31 | C$7.53 M |